WEKA, which operates a monoclonal antibody infusion center at the former Golden Lion Hotel on 36th Avenue, has been open since early October, and has been collecting voluntary data from Covid patients who have received the treatment and are offered a survey.
To date, the survey suggests that a majority of people coming into the center for the treatment have already been vaccinated for Covid-19, and yet have become infected and are checking in for the treatment, the goal of which is to help prevent hospitalizations, reduce viral loads, and lessen symptom severity.
According to information obtained by Must Read Alaska, out of 235 patients who took the post-therapy WEKA survey, 197 had never had Covid-19 prior to the infection that led them to the WEKA center.
The takeaway is that of the 237 people who were treated for Covid with MAB, 135 were vaccinated (109 of which were vaccinated twice), and only 65-89 were unvaccinated. The conclusion may be that the pandemic is not among the unvaccinated, as President Biden claims.
The survey was voluntary and some of the participants did not answer all questions the same way.
For these clients, most had been vaccinated. Out of the 235 clients, 70 had not been vaccinated, while 125 had been vaccinated. That means 30 percent of the clients have been unvaccinated, while over 53 percent of the clients had been vaccinated. Three could not recall, and 12 preferred to not disclose their vaccination status.
Of the ones who had been vaccinated, 109 of them had received two doses of a two-dose series. Twelve more had had the two doses plus a booster shot.
The survey points to the increase in breakthrough cases of Covid, which is a phenomenon that has been characterized by medical officials at the CDC as rare.
“However, vaccine breakthrough infections occur in only a small fraction of all vaccinated persons and account for a small percentage of all COVID-19 cases,” the Centers for Disease Control and Prevention reports on its website.
Monoclonal antibody treatment is only available for those with a positive Covid diagnosis, and not all who sign up for it are eligible.
Monoclonal antibody treatment is available to individuals who:
- Are high risk for developing severe Covid-19 and
- Have a positive Covid-19 test and have not yet been admitted to the hospital and
- Are 12 years of age or older (and at least 88 pounds) and
- Are suffering from mild to moderate Covid-19
Contact the WEKA website if you get a positive test for Covid and are not needing hospitalization.
Other questions from the survey:
